Syros Pharmaceuticals, Inc. - common stock (SYRS) Social Stream



Syros Pharmaceuticals, Inc. - common stock (SYRS): $3.46

0.05 (+1.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SYROS PHARMACEUTICALS INC (SYRS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SYROS PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $23 $9 $17.2 $3.96 334.34%
2021-12-13 6 $23 $9 $17.2 $3.96 334.34%
2022-01-03 6 $23 $9 $17.6 $3.96 344.44%
2022-05-16 6 $23 $9 $16 $3.96 304.04%
2022-05-17 6 $23 $9 $14.333 $3.96 261.94%
2022-06-07 5 $19 $9 $11.6 $3.96 192.93%
2022-08-09 5 $19 $6 $10.8 $3.96 172.73%
2022-08-10 5 $19 $3 $9.6 $3.96 142.42%
2022-09-12 4 $19 $3 $9.6 $3.96 142.42%
2022-09-19 5 $190 $27 $81.4 $3.96 1955.56%
2022-11-06 5 $100 $27 $55.4 $3.96 1298.99%
2022-11-14 6 $100 $27 $55.4 $3.96 1298.99%
2022-11-15 6 $100 $15 $39.666 $3.96 901.67%

Over the past 48 weeks, SYRS's average upside potential has been 1,940.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-13 6 23 9 17.2 3.600 377.78%
2022-02-01 6 23 9 16.0 2.070 672.95%
2022-09-12 5 19 3 9.6 7.303 31.45%
2022-09-12 4 190 30 96.0 0.730 13050.68%
2022-09-12 5 190 30 96.0 0.730 13050.68%

SYRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 43 weeks, SYRS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, SYROS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1349.12% of them.
  • In the context of all US stocks, SYROS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1429.89% of them.
  • SYRS has a higher average analyst price target than 908.59% of stocks in the small market cap category.
  • In terms of how SYROS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 1045.24% of that group.

In the Pharmaceutical Products industry, CLSD, NOVN, and MRKR are the three stocks most similar to SYROS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is SYRS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7907 seconds.